BeyondSpring (NASDAQ:BYSI) received a new composition of matter patent for its lead asset, Plinabulin, from the U.S. Patent and Trademark Office. As a polymorph, Pinabulin can be converted into multiple crystalline...
Canopy Rivers (TSXV:RIV) announced that NETA NJ LLC, a company controlled by its portfolio company, TerrAscend (CSE:TER; OTCQX:TRSSF), has been selected by the State of New Jersey Department of Health to apply for final...
LexaGene Holdings (OTCQB:LXXGF; TSX-V:LXG) has completed development of a syndromic panel to detect urinary tract infection (UTI) in small animals. The assay is capable of detecting each of the eight most common...
Researchers in Australia have developed a simple blood test they claim can diagnose cancer in 10 minutes by identifying a unique DNA signature present in all types of the disease. While the test has yet to be studied in...
Canopy Growth (TSX:WEED; NYSE:CGC) finalized an all-cash transaction to acquire Storz & Bickel GmbH for up to approximately €145-million. Storz & Bickel is widely recognized as the global leader in vaporizer...
BeyondSpring (NASDAQ:BYSI) announced that the Phase 3 portion of its Study 105 evaluating its lead asset, Plinabulin, in patients treated with docetaxel chemotherapy has met its primary endpoint of non-inferiority...
Closely-held Scientus Pharma, through its HydRx Farms unit, received a U.S. patent that provides intellectual property protection for its decarboxylation method for extraction and activation of active pharmaceutical...
BeyondSpring (NASDAQ:BYSI) reported new data from its lead asset, Plinabulin, for the prevention of chemotherapy-induced neutropenia (CIN) at the American Society of Hematology (ASH) annual meeting. Plinabulin is...
Canopy Growth (TSX:WEED; NYSE: CGC) inked an investment financing, and partnership and a supply agreement with 48North Cannabis (TSXV:NRTH). Under the supply accord, 48North would supply Canopy with dried cannabis...
Canopy Growth (TSX:WEED; NYSE:CGC) has entered an 18-month strategic supply agreement with a unit of MediPharm Labs (TSXV:LABS) to purchase up to 900 kg of cannabis extract. Canopy Growth has committed to purchase a...
Health Canada approved Opsens’ (TSX:OPS; OTCQX:OPSSF) diastolic pressure ratio (dPR) proprietary resting index, which measures intracoronary pressure and establishes a diagnosis with the heart at rest to guide treatment...
Canopy Growth (TSX:WEED; NYSE: CGC) has completed four product transfers of legal cannabis to Ohio-based Battelle, the world’s largest non-profit research and development organization, to support medical research...
Leerink initiated coverage of 10 biopharma and generic stocks, saying the sector is rich with companies developing drugs with the aim to treat and/or definitively cure conditions ranging from rare, severe inherited...
Following a successful pre-IND meeting with FDA, closely-held Interface Biologics (IBI) is preparing to initiate a Phase 2 trial with its dexamethasone intravitreal implantin patients with diabetic macular edema. The...
Canopy Growth (TSX:WEED; NYSE:CGC) completed the acquisition of the assets of ebbu, a leader in hemp research and innovation, for $25-million and 6,221,210 common shares. Under the accord, Canopy would pay up to an...
Closely-held Lobo Genetics entered into a non-binding letter of intent with Cassowary Capital (TSXV:BIRD) that will result in a reverse takeover of Cassowary by Lobo. Cassowary is a capital pool company on the TSX...
Canopy Rivers’ (TSXV:RIV) portfolio company, Radicle Medical Marijuana, received a production and sales licence from Health Canada to supply and sell finished cannabis products for both the medical and adult-use market...
Analysts for Canaccord Genuity, Echelon Wealth Partners and A.G.P./Alliance Global Partners are raising the prospects of Profound Medical’s (OTCQX:PRFMF; TSX:PRN) TULSA-PRO device as a treatment for benign prostatic...
Constellation Brands (NYSE:STZ) closed its $5-billion (Canadian) investment in Canopy Growth (TSX:WEED; NYSE:CGC) following approval by Canopy shareholders and all regulatory agencies, including the Canadian government...
A joint research project between closely-held elminda of Israel and The Villages Health of Florida will receive the prestigious Erickson Foundation Award for Excellence in Aging Research at the upcoming 2018 American...
Closely-held Scientus Pharma updated its collaboration with Generex Biotechnology (OTCQB:GNBT) to co-develop products for the delivery of cannabinoids via the buccal mucosa, or inner lining of the mouth. Having recently...
Closely-held Physicians Endoscopy (PE) announced the addition of three GI ambulatory surgery center (ASC) partnerships that were finalized between July and September of 2018. The partnerships increase PE’s...